Total Payments
$1,326
2024 Payments
$204.19
Companies
25
Transactions
92
Medicare Patients
4,398
Medicare Billing
$427,959
Payment Breakdown by Category
Food & Beverage$1,326 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,326 | 92 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $182.77 | 11 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $149.48 | 10 | $0 (2023) |
| IRONWOOD PHARMACEUTICALS, INC | $133.85 | 9 | $0 (2024) |
| GlaxoSmithKline, LLC. | $109.77 | 9 | $0 (2023) |
| Novo Nordisk Inc | $109.30 | 8 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $85.62 | 6 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $70.32 | 5 | $0 (2021) |
| Amgen Inc. | $68.10 | 4 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $57.82 | 5 | $0 (2022) |
| Lilly USA, LLC | $43.17 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $204.19 | 12 | ABBVIE INC. ($45.72) |
| 2023 | $176.52 | 11 | AbbVie Inc. ($71.19) |
| 2022 | $209.38 | 13 | ABBVIE INC. ($53.71) |
| 2021 | $251.31 | 19 | AstraZeneca Pharmaceuticals LP ($39.75) |
| 2020 | $114.66 | 9 | GlaxoSmithKline, LLC. ($49.96) |
| 2019 | $117.22 | 9 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($58.47) |
| 2018 | $147.34 | 11 | PFIZER INC. ($37.77) |
| 2017 | $105.21 | 8 | Novartis Pharmaceuticals Corporation ($25.92) |
All Payment Transactions
92 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $20.18 | General |
| Category: GI | ||||||
| 10/28/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $28.71 | General |
| Category: PSYCHIATRY | ||||||
| 09/16/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.78 | General |
| 06/18/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Diabetes | ||||||
| 06/03/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Psychology/Psychiatric | ||||||
| 04/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: NEUROSCIENCE | ||||||
| 04/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: NEUROSCIENCE | ||||||
| 04/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Respiratory | ||||||
| 04/11/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $17.34 | General |
| Category: GI | ||||||
| 04/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Respiratory | ||||||
| 03/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: NEUROSCIENCE | ||||||
| 10/26/2023 | Shield Therapeutics Inc | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Hematology | ||||||
| 10/09/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Biological | ||||||
| 09/13/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA, SHINGRIX | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: RESPIRATORY | ||||||
| 07/24/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2023 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $16.44 | General |
| Category: GI | ||||||
| 06/20/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.36 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: INSOMNIA | ||||||
| 05/09/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: NEUROSCIENCE | ||||||
| 04/13/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/17/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: INSOMNIA | ||||||
| 12/07/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.52 | General |
| 11/18/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 245 | 525 | $60,255 | $36,596 |
| 2022 | 20 | 977 | 2,120 | $180,902 | $89,955 |
| 2021 | 26 | 1,478 | 4,650 | $264,580 | $145,381 |
| 2020 | 25 | 1,698 | 5,783 | $292,937 | $156,026 |
Total Patients
4,398
Total Services
13,078
Medicare Billing
$427,959
Procedure Codes
80
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 58 | 184 | $18,428 | $10,972 | 59.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 35 | 73 | $11,773 | $7,071 | 60.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 17 | 56 | $6,893 | $5,024 | 72.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 47 | 67 | $6,112 | $3,992 | 65.3% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 13 | 58 | $4,640 | $3,214 | 69.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 18 | 22 | $5,012 | $2,877 | 57.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 24 | 26 | $4,807 | $2,147 | 44.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 22 | 25 | $1,750 | $878.60 | 50.2% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 11 | 14 | $840.00 | $420.70 | 50.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 248 | 738 | $73,895 | $33,724 | 45.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 86 | 334 | $31,245 | $17,625 | 56.4% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 49 | 69 | $11,130 | $6,764 | 60.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 47 | 62 | $9,733 | $6,322 | 64.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 22 | 62 | $8,344 | $4,783 | 57.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 60 | 82 | $7,026 | $4,419 | 62.9% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 44 | 59 | $5,942 | $3,159 | 53.2% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 15 | 50 | $4,000 | $2,525 | 63.1% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 37 | 43 | $3,623 | $2,269 | 62.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 13 | 13 | $1,625 | $1,581 | 97.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 26 | 36 | $2,520 | $1,252 | 49.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 16 | 16 | $3,283 | $1,240 | 37.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 88 | 149 | $4,470 | $1,062 | 23.8% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2022 | 19 | 38 | $2,280 | $992.42 | 43.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 12 | $1,380 | $857.39 | 62.1% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 11 | 12 | $2,400 | $606.48 | 25.3% |
About Dr. William Carter, MD
Dr. William Carter, MD is a Family Medicine healthcare provider based in Tompkinsville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720013873.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Carter, MD has received a total of $1,326 in payments from pharmaceutical and medical device companies, with $204.19 received in 2024. These payments were reported across 92 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($1,326).
As a Medicare-enrolled provider, Carter has provided services to 4,398 Medicare beneficiaries, totaling 13,078 services with total Medicare billing of $427,959. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Tompkinsville, KY
- Active Since 07/11/2006
- Last Updated 06/29/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1720013873
Products in Payments
- VRAYLAR (Drug) $182.77
- Linzess (Drug) $133.85
- ENTRESTO (Drug) $113.50
- TRELEGY ELLIPTA (Drug) $59.73
- TRULANCE (Drug) $58.47
- Otezla (Drug) $54.22
- FARXIGA (Drug) $39.75
- LYRICA (Drug) $37.77
- MOUNJARO (Drug) $32.20
- BREZTRI (Drug) $32.01
- INVOKANA (Drug) $30.11
- CAPLYTA (Drug) $28.71
- XARELTO (Drug) $27.71
- QUVIVIQ (Drug) $27.24
- Xofluza (Drug) $26.63
- ANORO ELLIPTA (Drug) $25.74
- Tresiba (Drug) $22.10
- AIMOVIG (Biological) $20.15
- Vivitrol 380 mg (Drug) $18.49
- ACCRUFER (Drug) $18.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Tompkinsville
Jerry Bean, M.d, M.D
Family Medicine — Payments: $1,422
Family Medicine $1,422
Jack Anderson, Do, DO
Family Medicine — Payments: $1,344
Family Medicine $1,344
Dr. Timothy Hume, M.d, M.D
Family Medicine — Payments: $1,206
Family Medicine $1,206
Laura Inabnitt, Do, DO
Family Medicine — Payments: $413.50
Family Medicine $413.50
Caylan Mcpherson, Do, DO
Family Medicine — Payments: $300.02
Family Medicine $300.02
Mr. Kenneth Crabtree, Md, MD
Family Medicine
Family Medicine